Diflucan (fluconazole) is a prescription antifungal medication used to treat fungal infections. Some common side effects are ...

Discover a study that used the Skindex-29 assessment to evaluate emotional wellbeing during selumetinib cycles.

Researchers have found in a nonrandomised pilot trial that selumetinib showed a reduction in cutaneous neurofibromatosis ...

OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for ...

Hematopoietic and lymphocytic neoplasms (HLNs) are a diverse group of malignancies affecting blood and lymphatic systems, with outcomes varying from ...

Journey Medical plans to highlight the launch of Emrosi™ and showcase its line of prescription dermatology products. The FDA approved Emrosi for the treatment of inflammatory lesions of rosacea in ...

Despite its name, the presence of eosinophilia is not mandatory for the diagnosis of drug reaction with eosinophilia and systemic symptoms (DRESS syndrome). Early diagnosis and withdrawal of the ...

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome and haemophagocytic lymphohistiocytosis (HLH) are rare but severe immune-mediated diseases with overlapping clinical ...

Our data facilitate further investigation into the potential role of early-life vitamin D supplementation among children with a history of severe bronchiolitis and eosinophilia for preventing ...

The disease is mainly characterised by neutrophilic inflammation, but eosinophilia is known to predominate in 20% of the cases. Myeloid-derived suppressor cells (MDSCs) are immunomodulatory cells ...

Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also seen in ...